Pharma Journalist - Page 902 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Perrigo Signs Agreement To Divest Tysabri Royalty Stream For Up To $2.85 Billion

Enrollment Completed in Ligand’s Phase 2 Trial of LGD-6972 in Type 2 Diabetes

Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage XR

Xynomic Pharma has Acquired Worldwide Rights of Abexinostat

Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility

ANI Pharmaceuticals Acquires Inderal XL and InnoPran XL

Novartis wins CHMP nod for drug combo against some lung cancers

Cyclacel’s leukemia drug for elderly patients fails in key study

Finch Therapeutics Announces Strategic Collaboration with OpenBiome

Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments